FDAnews
www.fdanews.com/articles/192706-fda-grants-breakthrough-status-on-checkpoints-electrostimulation-therapy-system
FDA_Logo_Black_2016.gif

FDA Grants Breakthrough Status on Checkpoint’s Electrostimulation Therapy System

September 12, 2019

Checkpoint Surgical has earned the FDA’s breakthrough designation for its brief electrostimulation therapy system (BEST), a device designed to treat nerve injuries.

The device is intended to be used in combination with surgical intervention following nerve injury to speed up patient recovery.

BEST uses low-level electrical currents to stimulate a patient’s peripheral nerves and encourage nerve regeneration.

View today's stories